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Abstract 
 
Objectives: Endovenous methods are increasingly used to treat varicose veins. We 
evaluated the outcome of patients treated with the new RFA-ClosureFast catheter in an 
outpatient setting.  
Methods: Retrospective analysis of postinterventional duplex ultrasound (DUS), complication 
rate and quality of life of patients treated for incompetent saphenous veins.  
Results: Between 2007 and 2009 155 patients had been treated with ClosureFast. DUS was 
available from 73 (47%) patients (102 great (GSV) and 16 small (SSV) saphenous veins). 
After a mean follow-up of 12.2 months (range 1-29 months) DUS showed six (5.9%) open 
GSV and an occlusion of all treated SSV. One pulmonary embolism had occurred. Mean 
patient’s satisfaction was 8.7 (10=very satisfied), pain after one week 2.0 (no pain=0, 
maximal=10) and absence of work was 0.9 day (range 0-14 days).  
Conclusions: RFA for incompetent saphenous veins can safely be performed in an outpatient 
setting with a low complication rate, minimal pain and fast recovery.  
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Introduction 
 
The popularity of endovenous treatment for varicose veins has steadily increased over the 
past years. It allows to be treated as an outpatient and the return to work is quicker1-5. At the 
present time large patient studies and long-term follow-up of randomized trials comparing 
surgical methods with endovascular treatment modalities for varicose veins are not available. 
Darwood et al. published the results of 42 surgically treated legs compared with 29 legs 
treated with endovenous laser ablation (EVLA) and found comparable results regarding 
abolition of reflux and quality of life after three months2. Studies comparing different catheter-
directed techniques have been published; however many of them are retrospective studies6-8. 
In 2008, Luebke and Brunkwall published a meta-analysis including studies from 1970 to 
2007 of endovenous radiofrequency ablation (RFA), EVLA and foam sclerotherapy for 
primary varicosis9. They concluded that all these techniques “seem to be safe and effective 
modalities with good short and mid-term results”. However, RFA had the least favorable 
outcome and they suggested that a prospective, randomized study comparing surgery with 
endovascular techniques is needed. 
 
Van den Bos et al. could demonstrate quite clearly a superiority of laser light over 
radiofrequency (VNUS Closure)10. The original VNUS Closure technique can also be 
considered inferior to laser in terms of ease of handling. However, the original radiofrequency 
technique was replaced by the ClosureFast technique in 2007. The catheter embodies a 
heating coil with a length of 7cm at its tip heating the venous wall predictably to about 110 
degrees Celsius during 20 seconds. Thereafter, the catheter is pulled to the following 
segment and the next cycle begins. 
Proebstle et al. reported their initial experience with the new ClosureFast in 2008 in a 
prospective multicenter study involving 194 patients (252 GSV) with an average diameter of 
the treated vein of 5.7 mm and an occlusion rate of 99.6% at six months 11.  
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The aim of the present retrospective analysis was to evaluate patient satisfaction, the 
recurrence of saphenous reflux, complications and periprocedural pain after ClosureFast 
treatment in an outpatient setting. 
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Patients and Methods 
 
Patients treated from 2007 to 2009 for incompetent saphenous veins with ClosureFast 
radiofrequency ablation had been included in the analysis. All patients had symptoms or 
cosmetic disturbances from varicose veins. On ultrasound, reflux of more than one second 
was present in at least one saphenous vein. According to the CEAP classification, 70 
patients (45%) were classified C2 (visible varicosities), 60 patients (39%) C3 (oedema) and 
23 patients (15%) C4 (skin changes). Two patients had healed ulcers. Among all 
interventions performed for the treatment of varicose veins at the institution, the use of 
ClosureFast was 33% in 2007, 48% in 2008 and 64% in 2009. The reasons for stripping 
were a very superficial or very tortuous course of the varicose saphenous vein. However, the 
reimbursement question was crucial. In Switzerland, the majority of the numerous insurance 
companies do not reimburse endovascular methods. Therefore a considerable share of our 
patients decided to have an operation rather than paying the treatment by themselves.  
The catheter-based endovascular intervention with ClosureFast (Medical Technologies Inc., 
San Jose, California) has been described elsewhere12. In brief, depending on the extent of 
the insufficiency the puncture site of the vein can be above or below the knee or near the 
ankle. A 7-F catheter sheath is placed into the vein and the ClosureFast catheter advanced 
to the groin or to the popliteal fossa. The ClosureFast ablates the vein in 7cm segments with 
20-second treatment cycles at a temperature of 120 degrees Celsius and is withdrawn 
stepwise. The therapy is performed under tumescent local anaesthesia. The solution 
consisting of one litre of normal saline, 50ml Lidocain 1%, 1mg of adrenalin and 10ml 
potassium bicarbonate 8.4% is injected under ultrasound guidance around the refluxing vein 
with the catheter “in situ”, and around visible varicosities marked previously with a permanent 
marker in an upright position. The visible varicosities are treated by phlebectomy in the same 
session.  
After the procedure, absorbing gauzes and thigh compression stockings (20-30mmHg) were 
applied. Patients were discharged after the procedure and allowed to take off the bandages 
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the day after. Stockings were prescribed for one week. In order to reduce the 
thromboembolic risk patients were encouraged to avoid a sedentary lifestyle, but no 
anticoagulation was prescribed. All patients were asked to fill in two identical questionnaires 
in order to assess their quality of life score (CIVIQ2 questionnaire)13. The first questionnaire 
assessed baseline condition prior to the intervention, the second focused on 
postinterventional outcome. The scale for the variables was from one (no complaints/pain) to 
five (most intensive complaints/pain). Additionally, patients had been specifically asked to 
indicate on the questionnaire the days off work, the level of pain during and one week after 
the procedure, as well as satisfaction with treatment and with the result on a scale from zero 
(no pain/satisfaction) to ten (maximal pain/satisfaction). The questionnaires were sent by 
mail to the patients before the follow-up visit. Patients had been contacted by the operator if 
they were willing to come to the university hospital Zurich for an independent quality control 
including the questionnaires and a duplex ultrasound. 
Duplex ultrasound (DUS) was performed between one and 29 months after the procedure 
depending on patient’s availability to assess occlusion of the GSV defined as absence of flow 
20cm below the saphenous femoral junction (SFJ) and non-compressibility. Flow was also 
measured at 1 and 3cm and the vein diameter at 3 and 20cm distal to the SFJ. Furthermore, 
flow and compressibility of the femoral and popliteal vein as well as calf veins were tested in 
order to detect deep venous thrombosis. In SSV successful occlusion was defined as no flow 
over the treated length of the vein and non-compressibility. In veins with flow the presence of 
reflux was tested by distal decompression and proximal compression and in GSV also with 
Valsalva maneuver.  
 
Statistics 
 
All statistical analyses were made with the SPSS 17 for Windows using Wilcoxon signed 
rank test for intragroup and Mann-Whitney U test for intergroup comparison. A p value of less 
than 0.05 was considered significant. 
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Results 
 
From 2007 to 2009 190 GSV and 42 SSV of 155 (111 female) patients were treated with the 
ClosureFast technique. In all patients the GSV and/or SSV were successfully accessed 
percutaneously via ultrasound-guided puncture. The puncture site was above the knee in 29 
(12.5%), below the knee in 139 (60%) and near the ankle in 64 (27.5%) cases. On average 
six segments (range 2-10) of the GSV were treated and three (1-5) segments of the SSV. 
The mean treatment length was 45cm (range 13-75cm) for the GSV and 23cm (range 7-
35cm) for the SSV. The proximal segments of the GSV were treated with two cycles if the 
vein had a diameter of more than 8mm. All refluxing saphenous veins were treated and all 
varicose branches removed by hook phlebectomy in the same session.  
 
 
CIVIQ2 questionnaire  
Ninety-four (60.6%) patients had returned the questionnaires. The results of the 
questionnaires are given in table 1 and 2. In all patients quality of life score improved after 
the procedure. The mean value for pain during the procedure was 3.1 (range 0-10) and for 
pain one week after the intervention 2.0 (range 0-10). Pain was independent from the treated 
vein and was similar in patients treated bilaterally or unilaterally (p>0.05). Patients went back 
to work after a mean time of 0.9 days (range 0-14 days). Seventy-six (82%) patients had no 
inability to work at all. The overall satisfaction with the treatment was 8.7 (range 1-10) and 
satisfaction with the final result was 8.0 (range 1-10) on a scale from zero (not at all) to ten 
(fully satisfied) and there was no difference in patients treated for GSV or SVV, bilaterally or 
unilaterally.  
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Duplex Ultrasound 
Data of DUS were available from 73 (47%) patients in which 118 saphenous veins had been 
treated (102 GSV, 16 SSV). The residual 82 patients were not willing to come for a control 
DUS. The mean follow-up time was 12.2 months (range 1-29 months). Baseline statistics are 
given in table 3. The mean age of the patients was 54 years (range 19-89 years). Six (5.9%) 
of the 102 treated GSV (four patients) were open defined as flow in the treated GSV 20cm 
below the SFJ. None of the open GSV showed reflux 20cm below the SFJ. Flow was 
detected in 78 (76.5%) veins at 1cm and in 13 (12.7%) veins at 3cm below SFJ. No flow 
signal was detected in any of the treated SSV (table 4). 
For the GSV the mean diameter was 0.3cm (range 0-1.0cm) at 3cm and 0.2cm (range 0-
0.8cm) at 20cm below the SFJ. In SSV mean diameter was 0.2cm (range 0-0.7cm) at 3cm 
and 0.1cm (range 0-0.6cm) at 20cm below the SFJ. The diameter of the GSV decreased with 
time and was significantly correlated with the follow-up time (p<0.0001). 
Four patients with open GSV suffered significantly more pain during the first week (mean 
4.75, range 3-8 versus mean 1.90, range 0-10; p=0.001) compared to those with occluded 
veins. Furthermore, the diameter was significantly larger at 3cm (mean 0.65cm, range 0.32-
0.9cm) and at 20cm (mean 0.38cm, range 0.2-0.59cm; p=0.007) below SFJ in open 
compared to occluded veins. Despite the open vein no reflux was present. Follow-up time, 
age and BMI did not influence the result of DUS. 
 
Adverse events 
The adverse events are summarized in table 5. Ten (13.7%) patients (4.2% of treated veins) 
reported paresthesia witch was not specifically verified by an objective method. Four (5.5%) 
patients developed hyperpigmentation. In one patient a thrombophlebitis occurred at the 
puncture site and one patient suffered from a pulmonary embolism two weeks after the 
intervention. This patient was later diagnosed with a thrombophilia. No deep venous 
thrombosis was detected by DUS. No residual varicose veins were detectable. All patients 
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were satisfied with the outcome. No patients with leg ulcers had been treated. During follow-
up no leg ulcers had developed. 
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Discussion 
 
ClosureFast catheter 
Based on the published data there is sufficient evidence that catheter-directed heat 
application can be considered a safe procedure with good long-term results for the treatment 
of incompetent saphenous veins14-17.  We evaluated the results of RFA in an outpatient 
setting and focused on patient satisfaction and results from follow-up duplex ultrasound. The 
occlusion rate of 94.1% after one year in the present study is better than reported in other 
studies analyzing RFA with the older Closure catheter6. However, Proebstle et al. had 
reported a higher occlusion rate (99.6%) after 6 months with the same catheter11. This might 
be explained by the fact that in our cohort the mean follow-up time was longer and therefore 
more recanalisation may have occurred. Still, even if some flow was detected in the treated 
vein, the diameter was small and no visible varicose veins had been present and no reflux 
was detected. Comparing our results with published data from EVLA the occlusion rate after 
one year is similar3-4. 
 
Adverse events 
It is difficult to compare the rate of side effects with other thermoablative methods because 
different energies are used. Furthermore, in most studies the new ClosureFAST catheter was 
tested against older EVLA-systems with lower wavelengths and no radial LASER-fiber. 
Interestingly, there are no data about side effects comparing the two RFA systems, the 
segmental RFA (ClosureFAST) and the bipolar RFA (Celon RFiTT). To our knowledge there 
is only one study comparing the old bipolar ClosurePLUS with the new segmental RFA 
(ClosureFAST), but side effects of the bipolar system are not mentioned18.  
The incidence of postinterventional phlebitis is lower in our patient group (1.4%) than it was 
reported for EVLT (2-6%)19-20. Paresthesia was found in 4.2% of treated veins and was 
independent of follow-up time. Slightly lower rates of paresthesia are published for EVLA (0-
2.34%) but also for RFA, thus it is unclear how the diagnosis of paresthesia was made18, 21-22. 
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The rather high rate of paresthesia in our cohort might be due to the fact that patients were 
asked by questionnaire about any type of paresthesia without specific explanation about the 
type of disturbance or exact location. Other side effects were similar in our patient group 
compared to published results of either EVLA or RFA. One patient (1.4%) developed a non-
fatal pulmonary embolism, but no deep venous thrombosis was detected. The reported 
incidence of deep venous thrombosis is low (0.3-7.7%) and not different in EVLA and RFA 
and so far pulmonary embolism has been reported only in single cases6,23-24. Selective 
adjunctive saphenous vein ligation has not proven a benefit regarding pulmonary embolism 
or long-time result25. 
 
Questionnaire  
Quality of life was analyzed using two questionnaires which were sent to the patient by mail 
(table 1). Pain and any limitations due to leg problems improved significantly after the 
intervention. Patients with varicose veins felt often tired due to leg problems and significant 
improvement was noted after the treatment. In addition, significant improvement of social 
function, sporting activities and housework was noted after therapy. These results show 
clearly how varicose veins influence daily activities and how treatment has a positive effect 
on important aspects of life. Patients with varicose veins feel often embarrassed which 
influences their social life. From our data we can conclude that quality of life in many different 
aspects improved after therapy which may lead to a healthier lifestyle (for example increased 
sporting activities after treatment).  
 
Costs 
Subramonia et al. showed that RFA is more expensive than conventional surgery26. In their 
study both treatments were performed in the operating room. The main difference in costs 
was due to the RFA catheter and the longer use of the operating room. Even the fact that 
RFA patients gained one working week did not compensate for these additional costs. All our 
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patients had been treated in an examination room and faster ablation was possible due to 
the new ClosureFast catheter.  
 
Learning curve  
One of the technical difficulties in heat ablation for varicose veins is ultrasound guided 
puncture. The main operator of the present series (ME) had limited experience in 
endovenous laser ablation before starting with the ClosureFast method. In the present 
series, all 155 ClosureFast procedures were carried out in cooperation with a very 
experienced physician (more than 1000 ultrasound guided punctures for EVLT orRFA). Well-
aimed and sufficient injection of tumescent local anaesthesia solution undoubtedly takes time 
to learn. At the beginning of the series more patient experienced pain and required 
interruption of the heating process and additional local anaesthesia than at a later stage. 
However, serious problems might occur when thermoablation is erroneously applied to 
proximal to the common femoral vein. We found it difficult on a few occasions in obese 
patients to exactly localise the tip of the catheter. In such a situation it is important to 
estimate the needed length of the catheter before it is introduced and the ultrasound probe 
needs to be perfectly parallel to the catheter in order to correctly localise the tip.  
 
Future 
A wide range of methods to produce and deliver heat have been presented in only one 
decade and there is no doubt that further techniques will evolve. With RFA technique 
repeated treatment of the saphenous vein during the same intervention might be necessary 
whereas with EVLA the pullback treatment time is shorter. Independent of the method it is 
crucial to carefully assess the venous anatomy prior to the intervention by DUS to localize 
incompetent branches, which may be treated at the same time by other means.  
Comparison of results is difficult due to different inclusion criteria regarding CEAP 
classification as well as different thermal energies, follow-up methods and periods and also 
operator experience. Therefore, it is desirable to develop a set of guidelines for clinical trials 
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evaluating endovenous ablative methods to ensure a consistent approach in design and 
reporting of data. 
 
Conclusion 
For several reasons including patients preference and health costs there is certainly a shift 
towards shorter hospitalization stay and outpatient treatments. Based on our data 
ClosureFast can be performed in an outpatient setting with a very high level of patient 
satisfaction, low postprocedural pain, low complication rate and almost immediate return to 
work.  
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